<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7409838\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="The U.S. Food and Drug Administration GCG Gallocatechin gallate HCV" exact="Hepatitis" post="C virus His-al (S)-2-amino-3-imidazolyl propanal HIV Human immunodeficiency virus"/>
  <result pre="gallate HCV Hepatitis C virus His-al (S)-2-amino-3-imidazolyl propanal HIV Human" exact="immunodeficiency" post="virus HCoV human coronavirus M Membrane protein MERS-CoV Middle"/>
  <result pre="virus HCoV human coronavirus M Membrane protein MERS-CoV Middle East" exact="respiratory" post="syndrome coronavirus MLPCN Molecular Libraries Probe Production Centers Network"/>
  <result pre="HCoV human coronavirus M Membrane protein MERS-CoV Middle East respiratory" exact="syndrome" post="coronavirus MLPCN Molecular Libraries Probe Production Centers Network Mpro"/>
  <result pre="RNA-dependent RNA polymerase S Spike protein SAR Structure-activity relationship SARS-CoV" exact="Severe" post="acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome"/>
  <result pre="RNA polymerase S Spike protein SAR Structure-activity relationship SARS-CoV Severe" exact="acute" post="respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus"/>
  <result pre="polymerase S Spike protein SAR Structure-activity relationship SARS-CoV Severe acute" exact="respiratory" post="syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2"/>
  <result pre="S Spike protein SAR Structure-activity relationship SARS-CoV Severe acute respiratory" exact="syndrome" post="coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 SFC"/>
  <result pre="SAR Structure-activity relationship SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2" exact="Severe" post="acute respiratory syndrome coronavirus 2 SFC Supercritical fluid chromatography"/>
  <result pre="Structure-activity relationship SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe" exact="acute" post="respiratory syndrome coronavirus 2 SFC Supercritical fluid chromatography SPR"/>
  <result pre="relationship SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute" exact="respiratory" post="syndrome coronavirus 2 SFC Supercritical fluid chromatography SPR Surface"/>
  <result pre="SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory" exact="syndrome" post="coronavirus 2 SFC Supercritical fluid chromatography SPR Surface plasmon"/>
  <result pre="SPR Surface plasmon resonance 1 Introduction 1.1 COVID-19 pandemic Coronavirus" exact="disease" post="2019 (COVID-19) is a highly infectious disease caused by"/>
  <result pre="1.1 COVID-19 pandemic Coronavirus disease 2019 (COVID-19) is a highly" exact="infectious disease" post="caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),"/>
  <result pre="COVID-19 pandemic Coronavirus disease 2019 (COVID-19) is a highly infectious" exact="disease" post="caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),"/>
  <result pre="2019 (COVID-19) is a highly infectious disease caused by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus that is"/>
  <result pre="(COVID-19) is a highly infectious disease caused by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), a virus that is closely"/>
  <result pre="is a highly infectious disease caused by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), a virus that is closely related"/>
  <result pre="more than 4.5 million people had been diagnosed with the" exact="infection" post="worldwide [2,3]. SARS-CoV-2 primarily spreads by small droplets expelled"/>
  <result pre="[6], and severe cases can progress to complications, including pneumonia," exact="acute" post="respiratory distress syndrome, multi-organ failure, and death [7]. The"/>
  <result pre="and severe cases can progress to complications, including pneumonia, acute" exact="respiratory" post="distress syndrome, multi-organ failure, and death [7]. The fatality"/>
  <result pre="forward single-stranded RNA [8,9], which is endowed with the largest" exact="viral" post="genomes (27â€&quot;32Â kb) among the RNA viruses identified to"/>
  <result pre="of all coronaviruses is composed of a minimum of three" exact="viral" post="proteins: (a) a spike protein (S), which is a"/>
  <result pre="time, coronaviruses have been recognized as important pathogens that cause" exact="respiratory" post="and gastrointestinal diseases in birds and mammals. Before SARS-CoV-2,"/>
  <result pre="been found to infect humans: HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory virus"/>
  <result pre="found to infect humans: HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and Middle East respiratory virus coronavirus"/>
  <result pre="to infect humans: HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory virus coronavirus (MERS-CoV)."/>
  <result pre="HCoV-HKU1, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East" exact="respiratory" post="virus coronavirus (MERS-CoV). The first four are constraint endemic"/>
  <result pre="the common cold, whereas the latter two can cause serious" exact="respiratory" post="epidemics [[16], [17], [18]]. SARS is an atypical viral"/>
  <result pre="cause serious respiratory epidemics [[16], [17], [18]]. SARS is an" exact="atypical" post="viral respiratory disease that resulted in 8098 cases and"/>
  <result pre="serious respiratory epidemics [[16], [17], [18]]. SARS is an atypical" exact="viral" post="respiratory disease that resulted in 8098 cases and 774"/>
  <result pre="respiratory epidemics [[16], [17], [18]]. SARS is an atypical viral" exact="respiratory" post="disease that resulted in 8098 cases and 774 reported"/>
  <result pre="epidemics [[16], [17], [18]]. SARS is an atypical viral respiratory" exact="disease" post="that resulted in 8098 cases and 774 reported deaths"/>
  <result pre="was successfully contained under joint efforts. MERS is a zoonotic" exact="respiratory" post="infection that initially broke out in the Middle East"/>
  <result pre="successfully contained under joint efforts. MERS is a zoonotic respiratory" exact="infection" post="that initially broke out in the Middle East in"/>
  <result pre="MERS coronavirus has thus far resulted in 2494 cases of" exact="infection" post="and 858 deaths. Based on the high prevalence and"/>
  <result pre="COVID-19. In addition, the combination of Î±-interferon and the anti-human" exact="immunodeficiency" post="virus (HIV) drug lopinavir/ritonavir (KaletraÂ®) has been used to"/>
  <result pre="development of highly specific and effective anti-coronavirus drugs against key" exact="viral" post="targets, particularly SARS-CoV-2, is urgently needed and would also"/>
  <result pre="functional nsp4âˆ¼nsp16 released by cleavage with 3CLpro are responsible for" exact="viral" post="genome replication and transcription, and nsp4âˆ¼nsp16 also play roles"/>
  <result pre="and transcription, and nsp4âˆ¼nsp16 also play roles in other important" exact="viral" post="life processes, such as protein translation, cleavage, and modification"/>
  <result pre="synthesis [34,39]. Therefore, the inhibition of 3CLpro can effectively block" exact="viral" post="RNA replication and transcription and further block viral proliferation."/>
  <result pre="effectively block viral RNA replication and transcription and further block" exact="viral" post="proliferation. Fig.Â 1 Coronavirus (SARS-CoV) genome. 3CLpro is highly"/>
  <result pre="is necessary for crossing the cell membrane and binding to" exact="viral" post="3CLpro. A pharmacokinetics study demonstrated that 4Â h after"/>
  <result pre="the 3-pyridyl group occupies the S1 pocket. Fig.Â 10 (A)" exact="Primary" post="SAR study of the furyl amide hit compound 39."/>
  <result pre="to the chlorine-substituted phenylethanol fragment yields GC813 (53), and its" exact="lower" post="IC50 value can be attributed to an extended conformation"/>
  <result pre="all four S1â€&quot;S4 subsites, and the resulting inhibitors have a" exact="lower" post="molecular weight and a reduced peptidyl character compared with"/>
  <result pre="including anti-HIV virus [85,86], anti-hepatitis C virus (HCV) [87], anti-mycobacterium" exact="tuberculosis" post="and anti-pathogenic activities [88,89]. In addition, isatin derivatives are"/>
  <result pre="3CLpro. 5 Discussion and perspectives As the cases of SASR-CoV-2" exact="infections" post="continue to rise, the development of effective drugs and"/>
  <result pre="inhibitors and natural product derivatives, and attempts to provide a" exact="complete" post="description of the structural characteristics of 3CLpro inhibitors, including"/>
  <result pre="PROTAC technology for the degradation of foreign proteins (such as" exact="viral" post="proteins) remains in its infancy. To date, only the"/>
  <result pre="block the biological function of coronavirus 3CLpro and its downstream" exact="viral" post="proteins and would therefore inhibit the assembly and replication"/>
  <result pre="this paper. References References 1WuF.ZhaoS.YuB.ChenY.WangW.SongZ.HuY.TaoZ.TianJ.PeiY.AÂ new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature579202026526932015508 2WuJ.T.LeungK.LeungG.M.Nowcasting and forecasting the potential domestic"/>
  <result pre="paper. References References 1WuF.ZhaoS.YuB.ChenY.WangW.SongZ.HuY.TaoZ.TianJ.PeiY.AÂ new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature579202026526932015508 2WuJ.T.LeungK.LeungG.M.Nowcasting and forecasting the potential domestic and"/>
  <result pre="2019-nCoV outbreak originating in Wuhan, China: a modelling studyLancet395202068969732014114 5ChanJ.F.YuanS.KokK.H.ToK.K.ChuH.YangJ.XingF.LiuJ.YipC.C.PoonR.W.TsoiH.W.LoS.K.ChanK.H.PoonV.K.ChanW.M.IpJ.D.CaiJ.P.ChengV.C.ChenH.HuiC.K.YuenK.Y.AÂ" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="in Wuhan, China: a modelling studyLancet395202068969732014114 5ChanJ.F.YuanS.KokK.H.ToK.K.ChuH.YangJ.XingF.LiuJ.YipC.C.PoonR.W.TsoiH.W.LoS.K.ChanK.H.PoonV.K.ChanW.M.IpJ.D.CaiJ.P.ChengV.C.ChenH.HuiC.K.YuenK.Y.AÂ familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  <result pre="transmission: a study of a family clusterLancet (London, England)3952020514523 6ZhouP.YangX.L.WangX.G.HuB.ZhangL.ZhangW.SiH.R.ZhuY.LiB.HuangC.L.ChenH.D.ChenJ.LuoY.GuoH.JiangR.D.LiuM.Q.ChenY.ShenX.R.WangX.ZhengX.S.ZhaoK.ChenQ.J.DengF.LiuL.L.YanB.ZhanF.X.WangY.Y.XiaoG.F.ShiZ.L.AÂ" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="BoheemenS.de GraafM.LauberC.BestebroerT.M.RajV.S.ZakiA.M.OsterhausA.D.M.E.HaagmansB.L.GorbalenyaA.E.SnijderE.J.FouchierR.A.M.Genomic characterization of a newly discovered coronavirus associated with" exact="acute" post="respiratory distress syndrome in humansmBio32012e00473-00412 10NukoolkarnV.LeeV.S.MalaisreeM.AruksakulwongO.HannongbuaS.Molecular dynamic simulations analysis"/>
  <result pre="GraafM.LauberC.BestebroerT.M.RajV.S.ZakiA.M.OsterhausA.D.M.E.HaagmansB.L.GorbalenyaA.E.SnijderE.J.FouchierR.A.M.Genomic characterization of a newly discovered coronavirus associated with acute" exact="respiratory" post="distress syndrome in humansmBio32012e00473-00412 10NukoolkarnV.LeeV.S.MalaisreeM.AruksakulwongO.HannongbuaS.Molecular dynamic simulations analysis of"/>
  <result pre="of a newly discovered coronavirus associated with acute respiratory distress" exact="syndrome" post="in humansmBio32012e00473-00412 10NukoolkarnV.LeeV.S.MalaisreeM.AruksakulwongO.HannongbuaS.Molecular dynamic simulations analysis of ritonavir and"/>
  <result pre="targeting a 3C-like proteaseProtein Cell4201324825023549610 14WuX.D.ShangB.YangR.F.YuH.MaZ.H.ShenX.JiY.Y.LinY.WuY.D.LinG.M.TianL.GanX.Q.YangS.JiangW.H.DaiE.H.WangX.Y.JiangH.L.XieY.H.ZhuX.L.PeiG.LiL.WuJ.R.SunB.The spike protein of severe" exact="acute" post="respiratory syndrome (SARS) is cleaved in virus infected Vero-E6"/>
  <result pre="a 3C-like proteaseProtein Cell4201324825023549610 14WuX.D.ShangB.YangR.F.YuH.MaZ.H.ShenX.JiY.Y.LinY.WuY.D.LinG.M.TianL.GanX.Q.YangS.JiangW.H.DaiE.H.WangX.Y.JiangH.L.XieY.H.ZhuX.L.PeiG.LiL.WuJ.R.SunB.The spike protein of severe acute" exact="respiratory" post="syndrome (SARS) is cleaved in virus infected Vero-E6 cellsCell"/>
  <result pre="3C-like proteaseProtein Cell4201324825023549610 14WuX.D.ShangB.YangR.F.YuH.MaZ.H.ShenX.JiY.Y.LinY.WuY.D.LinG.M.TianL.GanX.Q.YangS.JiangW.H.DaiE.H.WangX.Y.JiangH.L.XieY.H.ZhuX.L.PeiG.LiL.WuJ.R.SunB.The spike protein of severe acute respiratory" exact="syndrome" post="(SARS) is cleaved in virus infected Vero-E6 cellsCell Res.14200440040615450134"/>
  <result pre="mechanism, animal models and novel therapeutic interventions for Middle East" exact="respiratory" post="syndrome coronavirus infectionsFront. Microbiol.10201956930984127 17MustafaS.BalkhyH.GabereM.N.Current treatment options and the"/>
  <result pre="animal models and novel therapeutic interventions for Middle East respiratory" exact="syndrome" post="coronavirus infectionsFront. Microbiol.10201956930984127 17MustafaS.BalkhyH.GabereM.N.Current treatment options and the role"/>
  <result pre="role of peptides as potential therapeutic components for Middle East" exact="Respiratory" post="Syndrome (MERS): a reviewJ.Â Infect. Public Health11201791728864360 18HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East"/>
  <result pre="of peptides as potential therapeutic components for Middle East Respiratory" exact="Syndrome" post="(MERS): a reviewJ.Â Infect. Public Health11201791728864360 18HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East respiratory"/>
  <result pre="Respiratory Syndrome (MERS): a reviewJ.Â Infect. Public Health11201791728864360 18HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East" exact="respiratory" post="syndrome coronavirus: risk factors and determinants of primary, household,"/>
  <result pre="Syndrome (MERS): a reviewJ.Â Infect. Public Health11201791728864360 18HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East respiratory" exact="syndrome" post="coronavirus: risk factors and determinants of primary, household, and"/>
  <result pre="household, and nosocomial transmissionLancet. Infect. Dis.182018e217e22729680581 19ZiebuhrJ.Molecular biology of severe" exact="acute" post="respiratory syndrome coronavirusCurr. Opin. Microbiol.7200441241915358261 20RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PeÃ±arandaS.BankampB.MaherK.ChenM.H.TongS.TaminA.LoweL.FraceM.DeRisiJ.L.ChenQ.WangD.ErdmanD.D.PeretT.C.BurnsC.KsiazekT.G.RollinP.E.SanchezA.LiffickS.HollowayB.LimorJ.McCaustlandK.Olsen-RasmussenM.FouchierR.GÃ¼ntherS.OsterhausA.D.DrostenC.PallanschM.A.AndersonL.J.BelliniW.J.Characterization of a novel"/>
  <result pre="and nosocomial transmissionLancet. Infect. Dis.182018e217e22729680581 19ZiebuhrJ.Molecular biology of severe acute" exact="respiratory" post="syndrome coronavirusCurr. Opin. Microbiol.7200441241915358261 20RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PeÃ±arandaS.BankampB.MaherK.ChenM.H.TongS.TaminA.LoweL.FraceM.DeRisiJ.L.ChenQ.WangD.ErdmanD.D.PeretT.C.BurnsC.KsiazekT.G.RollinP.E.SanchezA.LiffickS.HollowayB.LimorJ.McCaustlandK.Olsen-RasmussenM.FouchierR.GÃ¼ntherS.OsterhausA.D.DrostenC.PallanschM.A.AndersonL.J.BelliniW.J.Characterization of a novel coronavirus"/>
  <result pre="nosocomial transmissionLancet. Infect. Dis.182018e217e22729680581 19ZiebuhrJ.Molecular biology of severe acute respiratory" exact="syndrome" post="coronavirusCurr. Opin. Microbiol.7200441241915358261 20RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PeÃ±arandaS.BankampB.MaherK.ChenM.H.TongS.TaminA.LoweL.FraceM.DeRisiJ.L.ChenQ.WangD.ErdmanD.D.PeretT.C.BurnsC.KsiazekT.G.RollinP.E.SanchezA.LiffickS.HollowayB.LimorJ.McCaustlandK.Olsen-RasmussenM.FouchierR.GÃ¼ntherS.OsterhausA.D.DrostenC.PallanschM.A.AndersonL.J.BelliniW.J.Characterization of a novel coronavirus associated"/>
  <result pre="Opin. Microbiol.7200441241915358261 20RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PeÃ±arandaS.BankampB.MaherK.ChenM.H.TongS.TaminA.LoweL.FraceM.DeRisiJ.L.ChenQ.WangD.ErdmanD.D.PeretT.C.BurnsC.KsiazekT.G.RollinP.E.SanchezA.LiffickS.HollowayB.LimorJ.McCaustlandK.Olsen-RasmussenM.FouchierR.GÃ¼ntherS.OsterhausA.D.DrostenC.PallanschM.A.AndersonL.J.BelliniW.J.Characterization of a novel coronavirus associated with severe" exact="acute" post="respiratory syndromeScience30020031394139912730500 21DrostenC.GÃ¼ntherS.PreiserW.van der WerfS.BrodtH.R.BeckerS.RabenauH.PanningM.KolesnikovaL.FouchierR.A.BergerA.BurguiÃ¨reA.M.CinatlJ.EickmannM.EscriouN.GrywnaK.KrammeS.ManuguerraJ.C.MÃ¼llerS.RickertsV.StÃ¼rmerM.ViethS.KlenkH.D.OsterhausA.D.SchmitzH.DoerrH.W.Identification of a novel coronavirus"/>
  <result pre="Microbiol.7200441241915358261 20RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PeÃ±arandaS.BankampB.MaherK.ChenM.H.TongS.TaminA.LoweL.FraceM.DeRisiJ.L.ChenQ.WangD.ErdmanD.D.PeretT.C.BurnsC.KsiazekT.G.RollinP.E.SanchezA.LiffickS.HollowayB.LimorJ.McCaustlandK.Olsen-RasmussenM.FouchierR.GÃ¼ntherS.OsterhausA.D.DrostenC.PallanschM.A.AndersonL.J.BelliniW.J.Characterization of a novel coronavirus associated with severe acute" exact="respiratory" post="syndromeScience30020031394139912730500 21DrostenC.GÃ¼ntherS.PreiserW.van der WerfS.BrodtH.R.BeckerS.RabenauH.PanningM.KolesnikovaL.FouchierR.A.BergerA.BurguiÃ¨reA.M.CinatlJ.EickmannM.EscriouN.GrywnaK.KrammeS.ManuguerraJ.C.MÃ¼llerS.RickertsV.StÃ¼rmerM.ViethS.KlenkH.D.OsterhausA.D.SchmitzH.DoerrH.W.Identification of a novel coronavirus in"/>
  <result pre="der WerfS.BrodtH.R.BeckerS.RabenauH.PanningM.KolesnikovaL.FouchierR.A.BergerA.BurguiÃ¨reA.M.CinatlJ.EickmannM.EscriouN.GrywnaK.KrammeS.ManuguerraJ.C.MÃ¼llerS.RickertsV.StÃ¼rmerM.ViethS.KlenkH.D.OsterhausA.D.SchmitzH.DoerrH.W.Identification of a novel coronavirus in patients with severe" exact="acute" post="respiratory syndromeN.Â Engl. J. Med.34820031967197612690091 22CuiJ.LiF.ShiZ.L.Origin and evolution of"/>
  <result pre="WerfS.BrodtH.R.BeckerS.RabenauH.PanningM.KolesnikovaL.FouchierR.A.BergerA.BurguiÃ¨reA.M.CinatlJ.EickmannM.EscriouN.GrywnaK.KrammeS.ManuguerraJ.C.MÃ¼llerS.RickertsV.StÃ¼rmerM.ViethS.KlenkH.D.OsterhausA.D.SchmitzH.DoerrH.W.Identification of a novel coronavirus in patients with severe acute" exact="respiratory" post="syndromeN.Â Engl. J. Med.34820031967197612690091 22CuiJ.LiF.ShiZ.L.Origin and evolution of pathogenic"/>
  <result pre="novel subgenomic RNAs and noncanonical transcription initiation signals of severe" exact="acute" post="respiratory syndrome coronavirusJ.Â Virol.7920055288529515827143 31LiuX.WangX.Potential inhibitors for 2019-nCoV coronavirus"/>
  <result pre="subgenomic RNAs and noncanonical transcription initiation signals of severe acute" exact="respiratory" post="syndrome coronavirusJ.Â Virol.7920055288529515827143 31LiuX.WangX.Potential inhibitors for 2019-nCoV coronavirus M"/>
  <result pre="RNAs and noncanonical transcription initiation signals of severe acute respiratory" exact="syndrome" post="coronavirusJ.Â Virol.7920055288529515827143 31LiuX.WangX.Potential inhibitors for 2019-nCoV coronavirus M protease"/>
  <result pre="medicinesbioRxiv202010.1101/2020.01.29.924100Published online 29 January 2020 32YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.GaoG.F.AnandK.BartlamM.HilgenfeldR.RaoZ.The crystal structures of severe" exact="acute" post="respiratory syndrome virus main protease and its complex with"/>
  <result pre="online 29 January 2020 32YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.GaoG.F.AnandK.BartlamM.HilgenfeldR.RaoZ.The crystal structures of severe acute" exact="respiratory" post="syndrome virus main protease and its complex with an"/>
  <result pre="29 January 2020 32YangH.YangM.DingY.LiuY.LouZ.ZhouZ.SunL.MoL.YeS.PangH.GaoG.F.AnandK.BartlamM.HilgenfeldR.RaoZ.The crystal structures of severe acute respiratory" exact="syndrome" post="virus main protease and its complex with an inhibitorProc."/>
  <result pre="receptor bindingLancet (London, England)3952020565574 44WuF.ZhaoS.YuB.ChenY.M.WangW.SongZ.G.HuY.TaoZ.W.TianJ.H.PeiY.Y.YuanM.L.ZhangY.L.DaiF.H.LiuY.WangQ.M.ZhengJ.J.XuL.HolmesE.C.ZhangY.Z.AÂ new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature579202026526932015508 45WeiP.FanK.ChenH.MaL.HuangC.TanL.XiD.LiC.LiuY.CaoA.LaiL.The N-terminal octapeptide acts as a"/>
  <result pre="bindingLancet (London, England)3952020565574 44WuF.ZhaoS.YuB.ChenY.M.WangW.SongZ.G.HuY.TaoZ.W.TianJ.H.PeiY.Y.YuanM.L.ZhangY.L.DaiF.H.LiuY.WangQ.M.ZhengJ.J.XuL.HolmesE.C.ZhangY.Z.AÂ new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature579202026526932015508 45WeiP.FanK.ChenH.MaL.HuangC.TanL.XiD.LiC.LiuY.CaoA.LaiL.The N-terminal octapeptide acts as a dimerization"/>
  <result pre="(ML188) as potent noncovalent small molecule inhibitors of the severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) 3CL proteaseJ.Â Med. Chem.56201353454623231439 47KimY.MandadapuS.R.GroutasW.C.ChangK.O.Potent"/>
  <result pre="as potent noncovalent small molecule inhibitors of the severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) 3CL proteaseJ.Â Med. Chem.56201353454623231439 47KimY.MandadapuS.R.GroutasW.C.ChangK.O.Potent inhibition"/>
  <result pre="potent noncovalent small molecule inhibitors of the severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) 3CL proteaseJ.Â Med. Chem.56201353454623231439 47KimY.MandadapuS.R.GroutasW.C.ChangK.O.Potent inhibition of"/>
  <result pre="coronavirus 3C-like proteaseAntivir. Res.97201316116823219425 48GhoshA.K.XiK.RatiaK.SantarsieroB.D.FuW.HarcourtB.H.RotaP.A.BakerS.C.JohnsonM.E.MesecarA.D.Design and synthesis of peptidomimetic severe" exact="acute" post="respiratory syndrome chymotrypsin-like protease inhibitorsJ.Â Med. Chem.4820056767677116250632 49ZhuL.GeorgeS.SchmidtM.F.Al-GharabliS.I.RademannJ.HilgenfeldR.Peptide aldehyde"/>
  <result pre="3C-like proteaseAntivir. Res.97201316116823219425 48GhoshA.K.XiK.RatiaK.SantarsieroB.D.FuW.HarcourtB.H.RotaP.A.BakerS.C.JohnsonM.E.MesecarA.D.Design and synthesis of peptidomimetic severe acute" exact="respiratory" post="syndrome chymotrypsin-like protease inhibitorsJ.Â Med. Chem.4820056767677116250632 49ZhuL.GeorgeS.SchmidtM.F.Al-GharabliS.I.RademannJ.HilgenfeldR.Peptide aldehyde inhibitors"/>
  <result pre="proteaseAntivir. Res.97201316116823219425 48GhoshA.K.XiK.RatiaK.SantarsieroB.D.FuW.HarcourtB.H.RotaP.A.BakerS.C.JohnsonM.E.MesecarA.D.Design and synthesis of peptidomimetic severe acute respiratory" exact="syndrome" post="chymotrypsin-like protease inhibitorsJ.Â Med. Chem.4820056767677116250632 49ZhuL.GeorgeS.SchmidtM.F.Al-GharabliS.I.RademannJ.HilgenfeldR.Peptide aldehyde inhibitors challenge"/>
  <result pre="and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe" exact="acute" post="respiratory syndrome coronovirus (SARS-CoV) inhibitorsJ.Â Med. Chem.4920061198120116451084 52SydnesM.O.HayashiY.SharmaV.K.HamadaT.BachaU.BarrilaJ.FreireE.KisoY.Synthesis of"/>
  <result pre="synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute" exact="respiratory" post="syndrome coronovirus (SARS-CoV) inhibitorsJ.Â Med. Chem.4920061198120116451084 52SydnesM.O.HayashiY.SharmaV.K.HamadaT.BachaU.BarrilaJ.FreireE.KisoY.Synthesis of glutamic"/>
  <result pre="of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory" exact="syndrome" post="coronovirus (SARS-CoV) inhibitorsJ.Â Med. Chem.4920061198120116451084 52SydnesM.O.HayashiY.SharmaV.K.HamadaT.BachaU.BarrilaJ.FreireE.KisoY.Synthesis of glutamic acid"/>
  <result pre="group as SARS-CoV 3CL protease inhibitorsTetrahedron6220068601860932287416 53ShieJ.J.FangJ.M.KuoT.H.KuoC.J.LiangP.H.HuangH.J.WuY.T.JanJ.T.ChengY.S.WongC.H.Inhibition of the severe" exact="acute" post="respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated estersBioorg. Med."/>
  <result pre="as SARS-CoV 3CL protease inhibitorsTetrahedron6220068601860932287416 53ShieJ.J.FangJ.M.KuoT.H.KuoC.J.LiangP.H.HuangH.J.WuY.T.JanJ.T.ChengY.S.WongC.H.Inhibition of the severe acute" exact="respiratory" post="syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated estersBioorg. Med. Chem.1320055240525215994085"/>
  <result pre="SARS-CoV 3CL protease inhibitorsTetrahedron6220068601860932287416 53ShieJ.J.FangJ.M.KuoT.H.KuoC.J.LiangP.H.HuangH.J.WuY.T.JanJ.T.ChengY.S.WongC.H.Inhibition of the severe acute respiratory" exact="syndrome" post="3CL protease by peptidomimetic alpha,beta-unsaturated estersBioorg. Med. Chem.1320055240525215994085 54GhoshA.K.XiK.Grum-TokarsV.XuX.RatiaK.FuW.HouserK.V.BakerS.C.JohnsonM.E.MesecarA.D.Structure-based"/>
  <result pre="and evaluation of keto-glutamine analogues as potent inhibitors of severe" exact="acute" post="respiratory syndrome 3CLproJ.Â Med. Chem.4720046113611615566280 59ThanigaimalaiP.KonnoS.YamamotoT.KoiwaiY.TaguchiA.TakayamaK.YakushijiF.AkajiK.ChenS.E.Naser-TavakolianA.SchÃ¶nA.FreireE.HayashiY.Development of potent dipeptide-type"/>
  <result pre="evaluation of keto-glutamine analogues as potent inhibitors of severe acute" exact="respiratory" post="syndrome 3CLproJ.Â Med. Chem.4720046113611615566280 59ThanigaimalaiP.KonnoS.YamamotoT.KoiwaiY.TaguchiA.TakayamaK.YakushijiF.AkajiK.ChenS.E.Naser-TavakolianA.SchÃ¶nA.FreireE.HayashiY.Development of potent dipeptide-type SARS-CoV"/>
  <result pre="of keto-glutamine analogues as potent inhibitors of severe acute respiratory" exact="syndrome" post="3CLproJ.Â Med. Chem.4720046113611615566280 59ThanigaimalaiP.KonnoS.YamamotoT.KoiwaiY.TaguchiA.TakayamaK.YakushijiF.AkajiK.ChenS.E.Naser-TavakolianA.SchÃ¶nA.FreireE.HayashiY.Development of potent dipeptide-type SARS-CoV 3CL"/>
  <result pre="for design of improved Î±-ketoamide inhibitorsScience2020 64PillaiyarT.ManickamM.NamasivayamV.HayashiY.JungS.An overview of severe" exact="acute" post="respiratory syndromeâ€&quot;coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small"/>
  <result pre="design of improved Î±-ketoamide inhibitorsScience2020 64PillaiyarT.ManickamM.NamasivayamV.HayashiY.JungS.An overview of severe acute" exact="respiratory" post="syndromeâ€&quot;coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule"/>
  <result pre="protease inhibitorBioorg. Med. Chem.27201942543530558861 68TurlingtonM.ChunA.TomarS.EgglerA.Grum-TokarsV.JacobsJ.DanielsJ.S.DawsonE.SaldanhaA.ChaseP.Baez-SantosY.M.LindsleyC.W.HodderP.MesecarA.D.StaufferS.R.Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300"/>
  <result pre="inhibitorBioorg. Med. Chem.27201942543530558861 68TurlingtonM.ChunA.TomarS.EgglerA.Grum-TokarsV.JacobsJ.DanielsJ.S.DawsonE.SaldanhaA.ChaseP.Baez-SantosY.M.LindsleyC.W.HodderP.MesecarA.D.StaufferS.R.Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and"/>
  <result pre="Med. Chem.27201942543530558861 68TurlingtonM.ChunA.TomarS.EgglerA.Grum-TokarsV.JacobsJ.DanielsJ.S.DawsonE.SaldanhaA.ChaseP.Baez-SantosY.M.LindsleyC.W.HodderP.MesecarA.D.StaufferS.R.Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent"/>
  <result pre="Med. Chem.5420117962797322014094 75YangQ.ChenL.HeX.GaoZ.ShenX.BaiD.Design and synthesis of cinanserin analogs as severe" exact="acute" post="respiratory syndrome coronavirus 3CL protease inhibitorsChem. Pharmaceut. Bull.56200814001405 76RamajayamR.TanK.LiuH.LiangP.Synthesis"/>
  <result pre="Chem.5420117962797322014094 75YangQ.ChenL.HeX.GaoZ.ShenX.BaiD.Design and synthesis of cinanserin analogs as severe acute" exact="respiratory" post="syndrome coronavirus 3CL protease inhibitorsChem. Pharmaceut. Bull.56200814001405 76RamajayamR.TanK.LiuH.LiangP.Synthesis and"/>
  <result pre="75YangQ.ChenL.HeX.GaoZ.ShenX.BaiD.Design and synthesis of cinanserin analogs as severe acute respiratory" exact="syndrome" post="coronavirus 3CL protease inhibitorsChem. Pharmaceut. Bull.56200814001405 76RamajayamR.TanK.LiuH.LiangP.Synthesis and evaluation"/>
  <result pre="Commun.10201913130631068 105Rodriguez-GonzalezA.CyrusK.SalciusM.KimK.CrewsC.M.DeshaiesR.J.SakamotoK.M.Targeting steroid hormone receptors for ubiquitination and degradation in" exact="breast" post="and prostate cancerOncogene2720087201721118794799 106GaddM.S.TestaA.LucasX.ChanK.H.ChenW.LamontD.J.ZengerleM.CiulliA.Structural basis of PROTAC cooperative recognition"/>
  <result pre="protein degradationNat. Chem. Biol.13201751452128288108 107de WispelaereM.DuG.DonovanK.ZhangT.EleuteriN.YuanJ.KalabathulaJ.NowakR.FischerE.GrayN.YangP.Small molecule degraders of the" exact="hepatitis C" post="virus protease reduce susceptibility to resistance mutationsNat. Commun.10201911130602773 Acknowledgements"/>
  <result pre="WispelaereM.DuG.DonovanK.ZhangT.EleuteriN.YuanJ.KalabathulaJ.NowakR.FischerE.GrayN.YangP.Small molecule degraders of the hepatitis C virus protease reduce" exact="susceptibility to" post="resistance mutationsNat. Commun.10201911130602773 Acknowledgements This work was supported by"/>
 </snippets>
</snippetsTree>
